AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Zoetis Inc. (ZTS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

156.13

-1.39 (-0.88%)

At close: Feb 18, 2025, 3:59 PM

156.50

0.23%

After-hours: Feb 18, 2025, 06:26 PM EST

undefined% (undefined)

Bid	155.1
Market Cap	69.92B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	5.47
PE Ratio (ttm)	28.54
Forward PE	n/a
Analyst	Buy

Ask	156.69
Volume	5,701,114
Avg. Volume (20D)	2,761,469
Open	156.47
Previous Close	157.52
Day's Range	154.33 - 157.03
52-Week Range	144.80 - 200.53
Beta	undefined

About ZTS

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respirat...

[Show more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

IPO Date Feb 1, 2013

Employees 13,800

Stock Exchange NYSE

Ticker Symbol ZTS

Website https://www.zoetis.com

Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is $225, which is an increase of 44.11% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Zoetis Inc. is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 days ago

-4.49%

Zoetis shares are trading lower after Morgan Stanl... Unlock content with Pro Subscription

5 days ago

-5.15%

Zoetis shares are trading lower after the company issued FY25 guidance below estimates.

News

18 hours ago · youtube.com

Zoetis CEO on bird flu vaccine

Zoetis received a conditional license for its bird flu vaccine from the US Department of Agriculture to help fight the spread of the disease on poultry farms. Here's what CEO Kristin Peck had to say

5 days ago · fool.com

Why Zoetis Stock Took Another Tumble Today

One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (ZTS -4.49%) shares again tumbled. As of late-session trading on Friday, they were down b...

5 days ago · reuters.com

US grants conditional clearance to Zoetis' bird flu vaccine for poultry

Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry.

5 days ago · businesswire.com

Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #HPAI--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional lice...

6 days ago · youtube.com

Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval

Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.

6 days ago · seekingalpha.com

Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance, presenting a buying opportunity around $163/share. Zoetis' unique advantages and pricing powe...

5 days ago · zacks.com

Zoetis Stock Down Despite Q4 Earnings & Revenues Beat Estimates

ZTS stock falls despite better-than-expected fourth-quarter results due to a weak 2025 outlook.

5 days ago · seekingalpha.com

Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript

Zoetis Inc. (NYSE:ZTS ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Steve Frank - IR Kristin Peck - CEO Wetteny Joseph - CFO Conference Call Participants Michael...

5 days ago · fool.com

Why Zoetis Stock Was Falling Today

Shares of Zoetis (ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short in its fourth quarter.

5 days ago · fool.com

Zoetis Earnings Top Analysts' Forecasts

Zoetis (ZTS -8.79%), the leader in animal health solutions, released its fourth quarter results for 2024 on Feb. 13. The company reported an adjusted earnings per share (EPS) of $1.40, which exceeded ...

Load More News